Related Experiment Video
Updated: May 16, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Xenobiotic sulphation and its variability during inflammation: a factor in adverse drug reactions?
R H Waring1, R M Harris, J O Hunter
1Centre for Toxicology, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK. R.H.WARING@bham.ac.uk
Abstract:
The interactions between disease processes and the metabolism of therapeutic drugs have not been systematically investigated. Inflammation, with the presence of pro-inflammatory cytokines, affects Phase 1 metabolism, particularly the activity of the CYP isoforms. Inflammatory factors also alter the activity of some Phase 2 enzymes, particularly the sulphotransferases (SULT isoforms) responsible for drug sulphonation and the enzyme pathway involved in the supply of sulphate for this reaction. Being ill may, therefore, in itself make drug metabolism unpredictable.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Drug Toxicity: Dose-Dependent Reactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
